Aslan Fred bought ARTV
September 10, 2026 · Form 4 insider transaction
Aslan Fred bought 155,000 shares of Artiva Biotherapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
155,000
Price
$0.00
Total value
N/A
InsiderAslan Fred
RoleOfficer, Director
SecurityEmployee Stock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateSeptember 10, 2026
Filing dateSeptember 14, 2026
Shares owned after155,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Beginning on September 8, 2026, 1/48th of the shares subject to the option shall vest in equal monthly installments over a four-year period.